SHPCX Saratoga Health & Biotechnology C Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Regeneron Pharmaceuticals (NASDAQ:REGN), McKesson Corp (NYSE:MCK).

The investment seeks long-term capital growth. The fund will normally invest at least 80% of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value (or "market capitalization"). Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.

The average market capitalization across the Saratoga Health & Biotechnology C MF is 97.48B. The market cap for tickers in the group ranges from 10.44B to 220.19B. TMO holds the highest valuation in this group at 220.19B. The lowest valued company is THC at 10.44B.

The average weekly volume growth across all stocks in the Saratoga Health & Biotechnology C MF was -16%. For the same stocks of the MF, the average monthly volume growth was 8% and the average quarterly volume growth was 43%